Tourette syndrome and tic disorders affect individuals in deeply personal ways—interrupting daily life, complicating social dynamics, and often co-occurring with other challenges like ADHD or anxiety. At Alpine Psychiatry, we recognize the complex interplay of genetic, neurochemical, immune, and environmental factors in these conditions. Our integrative approach blends conventional treatment with innovative biomedical and therapeutic modalities to help individuals manage symptoms and improve quality of life.
Tic disorders involve sudden, involuntary movements or vocalizations. Tourette syndrome is diagnosed when both motor and vocal tics have been present for over a year. Tics may be simple (eye blinking, throat clearing) or complex (gestures, repeated phrases), and are often worsened by stress or fatigue.
Genetics: Multiple gene variants affect neurotransmitter signaling and immune pathways.
Inflammation: Allergies (asthma, eczema) and infections (e.g., strep) can increase tic frequency. Conditions like PANS/PANDAS often present with sudden onset tics.
ADHD: Commonly co-occurs, requiring coordinated care.
Gender and Age: Boys are more affected (4:1 ratio), with symptoms typically starting between ages 5–10.
Learn more about our care for PANS & PANDAS.
A gold standard therapy that includes habit reversal and competing response training. Shown to reduce tic severity by up to 31%.
Helps patients tolerate premonitory urges without performing the tic. A promising alternative when CBIT isn’t accessible.
Explore our therapy services for children and adults.
Clonidine / Guanfacine: Safe, non-stimulant options that help with tics, ADHD, and anxiety.
Guanfacine (Intuniv): Especially helpful for ADHD with co-occurring tics.
Aripiprazole, Risperidone, Pimozide: Highly effective for severe tics but with potential side effects. Aripiprazole is often best tolerated.
Pramipexole / Ropinirole: Investigated for tic reduction in Parkinson's and RLS; used off-label with growing interest.
Tetrabenazine / Deutetrabenazine: Reserved for refractory cases.
THC / CBD: Promising but still under investigation. May benefit select individuals under close supervision.
Low-frequency rTMS targeting the supplementary motor area has shown success in reducing tics with minimal side effects.
Non-invasive brain stimulation that shows early promise in reducing tics for up to six months post-treatment.
Surgical option for treatment-resistant cases, leading to 45–52% symptom reduction in select studies.
Help stabilize neurons and reduce excitability. Dosed gradually over 3 weeks and maintained for at least 4 months.
A study found a 30% decrease in tic severity in 71% of participants using this combination.
Deficiency correction may significantly reduce tic symptoms. Testing is essential before supplementing.
Supports GABAergic function; may reduce tics and is generally well-tolerated.
Used in Traditional Chinese Medicine to modulate neurotransmitters. Early studies from China suggest benefit, though quality control remains a concern.
A dopamine D1-receptor antagonist currently under review, with clinical trials showing positive outcomes in children.
At Alpine Psychiatry, we recognize that treating Tourette syndrome means looking at the whole person—not just the diagnosis. We integrate:
Medication management
Functional testing
Therapeutic support
Biomedical interventions
Nutritional supplementation
We partner with families to develop care plans that are compassionate, personalized, and evidence-based.
If you or your child is navigating the challenges of tics or Tourette syndrome, our team is here to help. Contact us today to schedule a consultation.
Guanfacine for ADHD
Clonidine and its broad applications
Magnesium’s role in mental health
Strattera (Atomoxetine) for ADHD
Vitamin D3 and mood regulation